-
ACLA Update on COVID-19 Testing Capacity
WASHINGTON, D.C – Following a surge of new COVID-19 cases in the United States, ACLA President Julie Khani issued the following statement: “ACLA member laboratories ... Read More -
ACLA Responds to New Tri-Agency Guidance, Calls on Federal Government to Address Newly-Created Coverage Gaps
WASHINGTON, D.C. – Following additional guidance released today from the Department of Labor, the Department of Treasury, and the Department of Health and Human Services ... Read More -
Amid Growing Demand For Testing, Lawmakers Call On HHS To Designate Resources For Clinical Laboratories
In a bipartisan letter to Secretary Azar, 30 lawmakers urge HHS to designate funds to help clinical laboratories expand capacity WASHINGTON, D.C. – As clinical ... Read More -
ACLA Statement on New Data Reporting Guidance
WASHINGTON, D.C. – As ACLA reviews the new data reporting guidance released today by the Department of Health and Human Services (HHS), ACLA President Julie Khani ... Read More -
ACLA Statement on Medicare Reimbursement Rate For Serologic Testing
WASHINGTON, D.C. – Following the release by the Centers for Medicare and Medicaid Services (CMS) of a reimbursement rate of $42.13 for the most commonly-performed ... Read More -
ACLA Statement on HEROES Act
WASHINGTON, D.C. — Following the introduction of the ‘‘Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act” ACLA President Julie Khani issued the following statement: “ACLA is currently ... Read More -
ACLA Statement on Expanding Access to Testing
WASHINGTON, D.C. — Following the Trump Administration’s announcements today on expanding access to testing, ACLA President Julie Khani released the following statement: “After scaling up to meet an ... Read More -
ACLA Statement on Support Necessary For Laboratories
WASHINGTON, D.C. — Following ongoing developments related to COVID-19 testing and response, ACLA President Julie Khani issued the following statement: “Labs are not scaling back. We’re ramping ... Read More -
ACLA Statement on FDA’s Revised Policy for Serologic Tests
WASHINGTON, D.C. – Following the revised policy on serologic testing announced today by the Food and Drug Administration, ACLA President Julie Khani issued the following ... Read More -
ACLA Statement on White House Meeting
WASHINGTON, D.C. – Following today’s meeting at the White House, ACLA President Julie Khani issued the following statement: “ACLA appreciated the opportunity to meet today ... Read More
